Department of Sports Medicine, Graduate School of Medicine, Nagoya University, Nagoya 464-8601, Japan.
Faculty of Pharmacy, Meijo University, Nagoya 468-8503, Japan.
Nutrients. 2022 Jan 18;14(3):404. doi: 10.3390/nu14030404.
d-Allulose, a rare sugar, improves glucose metabolism and has been proposed as a candidate calorie restriction mimetic. This study aimed to investigate the effects of d-allulose on aerobic performance and recovery from exhaustion and compared them with the effects of exercise training. Male C57BL/6J mice were subjected to exercise and allowed to run freely on a wheel. Aerobic performance was evaluated using a treadmill. Glucose metabolism was analyzed by an intraperitoneal glucose tolerance test (ipGTT). Skeletal muscle intracellular signaling was analyzed by Western blotting. Four weeks of daily oral administration of 3% d-allulose increased running distance and shortened recovery time as assessed by an endurance test. d-Allulose administration also increased the maximal aerobic speed (MAS), which was observed following treatment for >3 or 7 days. The improved performance was associated with lower blood lactate levels and increased liver glycogen levels. Although d-allulose did not change the overall glucose levels as determined by ipGTT, it decreased plasma insulin levels, indicating enhanced insulin sensitivity. Finally, d-allulose enhanced the phosphorylation of AMP-activated protein kinase and acetyl-CoA carboxylase and the expression of peroxisome proliferator-activated receptor γ coactivator 1α. Our results indicate that d-allulose administration enhances endurance ability, reduces fatigue, and improves insulin sensitivity similarly to exercise training. d-Allulose administration may be a potential treatment option to alleviate obesity and enhance aerobic exercise performance.
d-阿洛酮糖,一种稀有糖,可改善葡萄糖代谢,并被提议作为热量限制模拟物的候选物。本研究旨在探讨 d-阿洛酮糖对有氧性能和疲劳恢复的影响,并将其与运动训练的影响进行比较。雄性 C57BL/6J 小鼠进行运动,并允许在轮上自由奔跑。使用跑步机评估有氧性能。通过腹腔内葡萄糖耐量试验(ipGTT)分析葡萄糖代谢。通过 Western 印迹分析骨骼肌细胞内信号。每天口服 3%的 d-阿洛酮糖 4 周,可增加耐力测试中的跑步距离并缩短恢复时间。d-阿洛酮糖的给药还增加了最大有氧速度(MAS),在治疗 >3 或 7 天后即可观察到。改善的性能与较低的血液乳酸水平和增加的肝糖原水平相关。尽管 d-阿洛酮糖不会通过 ipGTT 测定总体葡萄糖水平,但它降低了血浆胰岛素水平,表明胰岛素敏感性增强。最后,d-阿洛酮糖增强了 AMP 激活的蛋白激酶和乙酰辅酶 A 羧化酶的磷酸化以及过氧化物酶体增殖物激活受体 γ 共激活剂 1α 的表达。我们的结果表明,d-阿洛酮糖给药可增强耐力,减轻疲劳并提高胰岛素敏感性,与运动训练相似。d-阿洛酮糖给药可能是一种潜在的治疗选择,可减轻肥胖并增强有氧运动表现。